R1 RCM Inc. (NASDAQ:RCM) Receives Average Recommendation of “Hold” from Brokerages

R1 RCM Inc. (NASDAQ:RCM) has received an average rating of “Hold” from the seventeen ratings firms that are currently covering the company, MarketBeat reports. Twelve equities research analysts have rated the stock with a hold recommendation and five have given a buy recommendation to the company. The average 1 year price target among brokers that have updated their coverage on the stock in the last year is $15.73.

Separately, Cantor Fitzgerald reiterated a “neutral” rating and set a $14.30 price target on shares of R1 RCM in a report on Friday, October 4th.

Institutional Inflows and Outflows

Several hedge funds have recently added to or reduced their stakes in RCM. GAMMA Investing LLC increased its position in R1 RCM by 41.3% in the 3rd quarter. GAMMA Investing LLC now owns 2,597 shares of the healthcare provider’s stock valued at $37,000 after acquiring an additional 759 shares during the period. Arizona State Retirement System raised its stake in shares of R1 RCM by 2.1% during the second quarter. Arizona State Retirement System now owns 47,063 shares of the healthcare provider’s stock valued at $591,000 after purchasing an additional 969 shares in the last quarter. Tidal Investments LLC lifted its holdings in R1 RCM by 8.1% in the third quarter. Tidal Investments LLC now owns 27,881 shares of the healthcare provider’s stock worth $395,000 after purchasing an additional 2,091 shares during the period. Victory Capital Management Inc. grew its position in R1 RCM by 7.7% in the 2nd quarter. Victory Capital Management Inc. now owns 36,006 shares of the healthcare provider’s stock valued at $452,000 after buying an additional 2,574 shares in the last quarter. Finally, Allspring Global Investments Holdings LLC increased its stake in R1 RCM by 589.2% during the 3rd quarter. Allspring Global Investments Holdings LLC now owns 3,122 shares of the healthcare provider’s stock valued at $44,000 after buying an additional 2,669 shares during the period. 61.10% of the stock is owned by institutional investors and hedge funds.

R1 RCM Price Performance

Shares of NASDAQ RCM opened at $14.31 on Monday. The company has a debt-to-equity ratio of 0.76, a quick ratio of 1.79 and a current ratio of 1.79. The firm has a fifty day moving average of $14.27 and a 200 day moving average of $13.68. The firm has a market cap of $6.04 billion, a PE ratio of -95.39 and a beta of 0.84. R1 RCM has a one year low of $8.87 and a one year high of $15.12.

R1 RCM (NASDAQ:RCM) last announced its quarterly earnings data on Tuesday, November 5th. The healthcare provider reported ($0.05) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.01) by ($0.04). R1 RCM had a negative net margin of 2.48% and a negative return on equity of 2.18%. The business had revenue of $656.80 million for the quarter, compared to analysts’ expectations of $640.93 million. The firm’s revenue was up 14.7% on a year-over-year basis. As a group, research analysts predict that R1 RCM will post -0.18 EPS for the current fiscal year.

R1 RCM Company Profile

R1 RCM Inc provides technology-driven solutions for the financial performance and patient experience of health systems, hospitals, and physician groups. It provides operating partnership/end-to-end solutions, which manages multiple aspects of the revenue cycle to realize financial leverage and revenue improvement for hospital and physician customers.